Suppr超能文献

用50%氯化锌溶液收敛剂治疗黑色素瘤切除伤口——无糊剂的莫氏黑色素瘤手术

Treatment of Melanoma Excision Wound With 50% Zinc Chloride Solution Astringent-Mohs Melanoma Surgery Without the Paste.

作者信息

Brooks Norman A

机构信息

Dr. Brooks is with the Skin Cancer Medical Center in Encino, California.

出版信息

J Clin Aesthet Dermatol. 2020 Mar;13(3):15-16. Epub 2020 Mar 1.

Abstract

Dr. Frederic Mohs believed that surgery can spread a melanoma; to prevent this, he applied an inactive black paste vehicle containing the active ingredient 50% zinc chloride solution to melanomas to kill and fix (i.e., preserve) tissue; this is termed . A statistically significant, 53-percent, five-year melanoma survival improvement in 103 consecutive cases was reported for fixed-tissue surgery compared to five-year survival for cases treated with conventional surgery (=0.003). Nine physicians, including the author, contributed to a melanoma registry of 179 cases between 1981 and 1991, and in 64 five-year determinate cases of thin melanomas (<0.85mm), survival was improved by 60 percent with zinc chloride paste simply applied after excision to the open fresh-tissue wound compared to conventional surgery (95.7% five-year survival with zinc chloride applied to the excision wound vs. 88.9% five-year survival with conventional fresh-tissue excision only, hazard ratio 0.37). When applied to an open fresh excision wound in either a solution or paste form, zinc chloride penetrates instantly; the author has found both forms to be equally effective. In solution form, the application technique is simple and similar to the astringent 20% aluminum chloride solution applied with sterile gauze or Q-tip, but the inactive paste vehicle requires special dressings. Additionally, the inactive paste used by Mohs contains stibnite antimony; therefore, it cannot be formulated to USP standards and is not recognized by the FDA as a generally safe substance. However, zinc chloride is recognized by the FDA as a generally safe substance, and the 50% solution can be formulated by a compounding pharmacist to USP standards. 50% zinc chloride solution penetrates deeply and kills tissue and should not be used without previous biopsy confirmation of melanoma or melanoma . The killing of tissue on the melanoma excision wound by the zinc chloride causes the wound to become deeper and wider, and therefore a smaller and thinner excision margin can be removed.

摘要

弗雷德里克·莫氏医生认为手术会扩散黑色素瘤;为防止这种情况,他将一种含有活性成分50%氯化锌溶液的无活性黑色糊剂载体涂抹在黑色素瘤上,以杀死并固定(即保存)组织;这被称为……。据报告,与接受传统手术的病例的五年生存率相比,连续103例固定组织手术的黑色素瘤五年生存率有统计学意义地提高了53%(P = 0.003)。包括作者在内的九名医生在1981年至1991年间为一个179例病例的黑色素瘤登记处做出了贡献,在64例五年期确诊的薄黑色素瘤(<0.85毫米)病例中,与传统手术相比,在切除后将氯化锌糊剂简单涂抹在新鲜开放组织伤口上,生存率提高了60%(氯化锌涂抹在切除伤口上的五年生存率为95.7%,仅传统新鲜组织切除的五年生存率为88.9%,风险比为0.37)。当以溶液或糊剂形式应用于新鲜开放的切除伤口时,氯化锌会立即渗透;作者发现两种形式同样有效。以溶液形式应用时,应用技术简单,类似于用无菌纱布或棉签涂抹收敛性的20%氯化铝溶液,但无活性糊剂载体需要特殊敷料。此外,莫氏使用的无活性糊剂含有辉锑矿锑;因此,它不能按照美国药典标准配制,也未被美国食品药品监督管理局认定为一般安全物质。然而,氯化锌被美国食品药品监督管理局认定为一般安全物质,50%的溶液可由配药药剂师按照美国药典标准配制。50%氯化锌溶液能深入渗透并杀死组织,在没有先前黑色素瘤或黑色素瘤活检确认的情况下不应使用。氯化锌对黑色素瘤切除伤口组织的杀伤会使伤口变得更深更宽,因此可以切除更小更薄的切缘。

相似文献

3
Frederic E. Mohs, MD, and the history of zinc chloride.医学博士弗雷德里克·E·莫氏与氯化锌的历史
Clin Dermatol. 2018 Jul-Aug;36(4):568-575. doi: 10.1016/j.clindermatol.2017.12.001. Epub 2017 Dec 28.
6
History of Mohs surgery.Mohs 手术的历史。
Dermatol Clin. 2011 Apr;29(2):135-9, vii. doi: 10.1016/j.det.2011.01.010.
7
Surgical margins for excision of primary cutaneous melanoma.原发性皮肤黑色素瘤切除的手术切缘
J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):422-9. doi: 10.1016/s0190-9622(97)70144-0.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验